Houlihan Lokey has named Sandy Purcell and Jean-Florent Rerolle as co-heads of the firm's European Financial Advisory Services (FAS) practice. Purcell is a managing director in the firm's London office, and previously headed its Mideast FAS practice. Rerolle is a managing director based in France. www.hlhz.com
Xangati, a Cupertino, Calif.-based provider of rapid problem identification (RPI) applications for enterprise networks, has raised $10.7 million in Series B funding. Walden International led the deal, with partner Mary Coleman joining the board of directors. Return backer Alloy Ventures also participated. www.xangati.com
Cellerix SL, a Tres Cantos, Spain-based developer of adult stem cell therapies, has raised EUR 27.2 million in new VC funding. Life Sciences Partners and Ventech co-led the round, and were joined by Roche Venture Fund, Novartis Venture Fund and Ysios Capital Partners. Return backers included former parent company Genetrix and Grupo A&G. www.cellerix.com
JapanBridge Inc., a Tokyo-based drug company, has raised $6.5 million in Series A-2 funding. Return backers MPM Capital and Itochu were joined by new strategic partner Kyowa Hakko Kogyo Co. Ltd., which will collaborate with JapanBridge on the commercialization of oncology and oncology supportive care assets in Japan. www.japanbridge.co.jp
Universal American Financial Corp. (Nasdaq: UHCO) has completed its acquisition of pharmacy benefits manager MemberHealth Inc., for approximately $630 million (55% cash, 45% UAF stock). The deal is being backed by a $350 million PIPE investment in UAF by Lee Equity Partners, Perry Capital, Union Square Partners Management (f.k.a. Capital Z) and Welsh, Carson, Anderson […]
Ysios Capital Partners of Barcelona, Spain is raising Euro 65 million for its debut fund, which will focus on venture capital opportunities in the biotech space. The firm will support early-stage companies, later-stage companies and pharmaceutical spinouts. Its team includes: managing partner Joel Jean Mairet, co-founder and CEO of Glycart Biotechnology AG; partner Christina Garmendia, […]
GenomeQuest Inc., a Westborough, Mass.-based provider of enterprise genomic search solutions, has raised $4 million in Series B funding. Mosaix Ventures led the deal, and was joined by return backers Cross Atlantic Partners, Milestone Venture Partners and Sociate Generale Asset Management. www.genomequest.com
CashView Inc., a Palo Alto, Calif.-based provider of electronic cash management services, has raised $6.5 million in Series B funding. Emergence Capital led the deal, and was joined by return backer DCM. www.cashview.com
TimeTrade Systems Inc., a Bedford, Mass.-based provider of appointment scheduling software, has raised $5 million in Series C funding. It is the company's first institutional round, with VentureWire reporting a post-money valuation of $21 million. Ascent Venture Partners led the deal, and was joined by return backer CommonAngels. www.timetrade.com
SnapVine Inc., a Seattle-based provider of mobile voice solutions for social networking sites, has raised $10 million in Series B funding. Bridgescale Partners led the deal, and was joined by return backers Draper Fisher Jurvetson and First Round Capital, according to The Seattle Post-Intelligencer. www.snapvine.com